Director, GU Oncology, Duke Cancer InstituteDepartments / Divisions
Durham, NC 27710
New drug development in prostate and kidney cancer, angiogenesis and targeted therapy, molecular and radiographic surrogate markers for biologic activity of tumors
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.